ArticleCureus2025
Frequency of Gastroesophageal Reflux Disease in Obese Patients Presenting to Lady Reading Hospital in Peshawar, Pakistan.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a serious health issue that affects millions of people worldwide and is associated with a number of comorbid conditions, including gastroesophageal reflux disease. The prevalence of gastroesophageal reflux disease increases with an increase in body mass index; thus, obese patients are at a high risk of developing gastroesophageal reflux disease. The main aim of this study was to determine the frequency of gastroesophageal reflux disease in patients with obesity.
methodsThis descriptive cross-sectional study was carried out at the Gastroenterology Department of Lady Reading Hospital in Peshawar, Pakistan, from June 1, 2023, to December 31, 2023. All obese patients (body mass index >30 kg/m
resultsAmong the total 282 obese patients, the majority (53.2%) were women. The mean age was 42.56 years with a standard deviation of 11.4 years. Most of the patients (168, 59.6%) were in the age range of 41-60 years. Seventy-three (25.8%) participants were having gastroesophageal reflux disease.
conclusionGastroesophageal reflux disease is quite common in obese patients. In particular, obese patients with a sedentary or sitting nature of job, older age, high body mass index, and injudicious use of non-steroidal anti-inflammatory drugs and who smoke are at high risk of developing gastroesophageal reflux disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.